scispace - formally typeset
J

Jody Vykoukal

Researcher at University of Texas MD Anderson Cancer Center

Publications -  111
Citations -  6022

Jody Vykoukal is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 33, co-authored 85 publications receiving 5383 citations. Previous affiliations of Jody Vykoukal include University of Texas Health Science Center at Houston & University of Texas System.

Papers
More filters
Journal ArticleDOI

Particle separation by dielectrophoresis

TL;DR: The application of dielectrophoresis to particle discrimination, separation, and fractionation is reviewed, some advantages and disadvantages of currently available approaches are considered, and some caveats are noted.
Journal ArticleDOI

Separation of Human Breast Cancer Cells From Blood by Differential Dielectric Affinity

TL;DR: Findings indicate that the dielectric affinity technique may prove useful in a wide variety of cell separation and characterization applications.
Journal ArticleDOI

Cell Separation by Dielectrophoretic Field-flow-fractionation

TL;DR: Dielectrophoretic field-flow-fractionation was applied to several clinically relevant cell separation problems, including the purging of human breast cancer cells from normal T-lymphocytes and from CD34+ hematopoietic stem cells, the separation of the major leukocyte subpopulations, and the enrichment of leukocytes from blood.
Journal ArticleDOI

Dielectrophoresis-based sample handling in general-purpose programmable diagnostic instruments

TL;DR: The concept of an integrated programmable general-purpose sample analysis processor (GSAP) architecture where raw samples are routed to separation and analysis functional blocks contained within a single device is presented.
Journal ArticleDOI

Droplet-based chemistry on a programmable micro-chip

TL;DR: A long-term goal of this research is to provide a platform fluidic processor technology that can form the core of versatile, automated, micro-scale devices to perform chemical and biological assays at or near the point of care, which will increase the availability of modern medicine to people who do not have ready access to modern medical institutions, and decrease the cost and delays associated with that lack of access.